Centro de Investigación en Artritis y Osteoporosis

Calzada de las Américas # 430 Col Cuauhtémoc sur, Mexicali Baja California 21200

Websitehttp://www.osteomed.mx/2014/

Select an option

I am a doctor

I am a sponsor

Specializations

Reumatología

Endocrinología

Open studies

Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus - Hoffmann-La Roche

Diabetes

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus - Hoffmann-La Roche

Rare diseases

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State - HZNP-DAZ-303 - Amgen

Renal disease

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads

Centro de Investigación en Artritis y Osteoporosis

Calzada de las Américas # 430 Col Cuauhtémoc sur, Mexicali Baja California 21200

Websitehttp://www.osteomed.mx/2014/

Select an option

I am a doctor

I am a sponsor

Specializations

Reumatología

Endocrinología

Open studies

Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus - Hoffmann-La Roche

Diabetes

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus - Hoffmann-La Roche

Rare diseases

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State - HZNP-DAZ-303 - Amgen

Renal disease

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads